Japan’s scheme for drug reimbursement under the national health insurance scheme is known for its complexity, with its detailed inner workings and regular revisions sometimes stumping even veteran industry insiders, despite its generally good transparency.
Part of the reason for the complexity appears to be an attempt to ensure fairness to the various aspects of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?